Loading tape…Loading tape…
CMI
CMI
CMI
CMI NASDAQ
A news headline reporting that Bristol Myers Squibb presented long-term efficacy and safety data for Camzyos at the European congress has circulated alongside market feeds for Cummins Inc. In terms of current fundamentals, Cummins Inc shows a market cap of approximately 77.38 billion, a P/E ratio of 28.54, and a trailing twelve-month EPS of 19.66. The company also recorded full-year revenue of 33.67 billion with a free cash flow yield of 4.35%.
Based on gurufocus.comBristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European
Beacon Pointe Advisors LLC Takes $9.56 Million Position in Cummins Inc. $CMI
Cummins (CMI) is a Top-Ranked Growth Stock: Should You Buy?
Hyperscalers Will Spend $750 Billion on AI This Year. Cummins Sells the Backup Power.
Here's Why Cummins (CMI) is a Strong Value Stock
Advisors Capital Management LLC Acquires Shares of 1,050 Cummins Inc. $CMI
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Stonks with professional market data, charts beside chat, and your portfolio context.
Tape shows delayed public market data. Not investment advice.